At 18, Hasina Subedar survived a near-fatal attack that inspired her to pursue a career in nursing. Now, three decades later, she is recognized as South Africa’s leading expert in HIV prevention, overseeing the rollout of lenacapavir, a highly effective twice-yearly injection, in 360 clinics nationwide. Her contributions have significantly shaped public health in South Africa, including authoring the Nursing Act of 2005 and becoming the first woman and person of color to lead the South African Nursing Council. Despite challenges, including funding cuts from the Trump administration, Subedar is determined to integrate lenacapavir into public healthcare systems, emphasizing the need for government-led initiatives over donor-dependent projects. Her leadership and experience in HIV prevention, particularly through previous PrEP initiatives, position her as a crucial figure in addressing the ongoing HIV crisis in the country.
Why It Matters
HIV remains a critical public health issue in South Africa, with millions affected by the virus. The introduction of lenacapavir offers a promising advancement in prevention strategies, especially in light of recent donor funding cuts that have hindered essential HIV services. Historically, South Africa has faced significant challenges in managing its HIV epidemic, with previous reliance on donor-driven health initiatives often resulting in fragmented care. The successful integration of lenacapavir into the public health system could potentially enhance access to preventive measures for vulnerable populations, thereby addressing some of the systemic gaps left by reduced international support.
Want More Context? 🔎
